Literature DB >> 3474626

Human plasma apolipoprotein C-II: total solid-phase synthesis and chemical and biological characterization.

T Fairwell, A V Hospattankar, H B Brewer, S A Khan.   

Abstract

The complete amino acid sequence of human plasma apolipoprotein C-II (apoC-II) has been synthesized chemically by the solid-phase method using phenylacetamidomethyl-resin. All amino acids were coupled to the peptide-resin in the presence of 1-hydroxybenzotriazole; tert-butyloxycarbonyl-protected amino acids with the appropriate side-chain-protecting groups that are stable to the reaction conditions used in the solid-phase methodology were used. After cleavage and deprotection, the crude apoC-II was purified by ion-exchange chromatography and then by reverse-phase high-performance liquid chromatography. The purified apolipoprotein was found to elute as a single peak under various chromatographic conditions, and the overall yield of the final purified protein was 20.7%. Synthetic apoC-II was characterized by several complementary analytical techniques including amino acid composition, Edman phenylisothiocyanate degradation, polyacrylamide gel electrophoresis, and high-performance liquid chromatography. The final product was found to be homogeneous and to activate normal human post-heparin lipase to the same extent as native apoC-II. The synthetic protein is also equally immunoreactive as native apoC-II.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3474626      PMCID: PMC305192          DOI: 10.1073/pnas.84.14.4796

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

Review 1.  The plasma lipoproteins: structure and metabolism.

Authors:  L C Smith; H J Pownall; A M Gotto
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

Review 2.  Solid-phase peptide synthesis.

Authors:  R B Merrifield
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1969

3.  The complete amino acid sequence of alanine apolipoprotein (apoC-3), and apolipoprotein from human plasma very low density lipoproteins.

Authors:  H B Brewer; R Shulman; P Herbert; R Ronan; K Wehrly
Journal:  J Biol Chem       Date:  1974-08-10       Impact factor: 5.157

4.  A specific apoprotein activator for lipoprotein lipase.

Authors:  J C LaRosa; R I Levy; P Herbert; S E Lux; D S Fredrickson
Journal:  Biochem Biophys Res Commun       Date:  1970-10-09       Impact factor: 3.575

5.  Rapid analysis of amino acid phenylthiohydantoins by high-performance liquid chromatography.

Authors:  C L Zimmerman; E Appella; J J Pisano
Journal:  Anal Biochem       Date:  1977-02       Impact factor: 3.365

Review 6.  Lipid-protein interactions in the plasma lipoproteins.

Authors:  J D Morrisett; R L Jackson; A M Gotto
Journal:  Biochim Biophys Acta       Date:  1977-08-09

7.  The lipids of the Golgi apparatus subfractions from rat liver.

Authors:  W Stremmel; H Debuch
Journal:  Biochim Biophys Acta       Date:  1979-05-25

8.  Interaction of synthetic peptides of apolipoprotein C-II and lipoprotein lipase at monomolecular lipid films.

Authors:  R L Jackson; A Balasubramaniam; R F Murphy; R A Demel
Journal:  Biochim Biophys Acta       Date:  1986-02-12

9.  Activation of lipoprotein lipase by native and synthetic fragments of human plasma apolipoprotein C-II.

Authors:  P K Kinnunen; R L Jackson; L C Smith; A M Gotto; J T Sparrow
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

10.  Hypertriglyceridemia associated with deficiency of apolipoprotein C-II.

Authors:  W C Breckenridge; J A Little; G Steiner; A Chow; M Poapst
Journal:  N Engl J Med       Date:  1978-06-08       Impact factor: 91.245

View more
  7 in total

1.  A nonsense mutation in the apolipoprotein C-IIPadova gene in a patient with apolipoprotein C-II deficiency.

Authors:  S S Fojo; P Lohse; C Parrott; G Baggio; C Gabelli; F Thomas; J Hoffman; H B Brewer
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

2.  Class B scavenger receptor types I and II and CD36 mediate bacterial recognition and proinflammatory signaling induced by Escherichia coli, lipopolysaccharide, and cytosolic chaperonin 60.

Authors:  Irina N Baranova; Tatyana G Vishnyakova; Alexander V Bocharov; Asada Leelahavanichkul; Roger Kurlander; Zhigang Chen; Ana C P Souza; Peter S T Yuen; Robert A Star; Gyorgy Csako; Amy P Patterson; Thomas L Eggerman
Journal:  J Immunol       Date:  2011-12-28       Impact factor: 5.422

3.  C-terminal domain of apolipoprotein CII as both activator and competitive inhibitor of lipoprotein lipase.

Authors:  Q Cheng; P Blackett; K W Jackson; W J McConathy; C S Wang
Journal:  Biochem J       Date:  1990-07-15       Impact factor: 3.857

4.  A role for the high-density lipoprotein receptor SR-B1 in synovial inflammation via serum amyloid-A.

Authors:  Ronan Hugh Mullan; Jennifer McCormick; Mary Connolly; Barry Bresnihan; Douglas James Veale; Ursula Fearon
Journal:  Am J Pathol       Date:  2010-03-19       Impact factor: 4.307

5.  Role of human CD36 in bacterial recognition, phagocytosis, and pathogen-induced JNK-mediated signaling.

Authors:  Irina N Baranova; Roger Kurlander; Alexander V Bocharov; Tatyana G Vishnyakova; Zhigang Chen; Alan T Remaley; Gyorgy Csako; Amy P Patterson; Thomas L Eggerman
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

6.  CD36 is a novel serum amyloid A (SAA) receptor mediating SAA binding and SAA-induced signaling in human and rodent cells.

Authors:  Irina N Baranova; Alexander V Bocharov; Tatyana G Vishnyakova; Roger Kurlander; Zhigang Chen; Dong Fu; Irwin M Arias; Gyorgy Csako; Amy P Patterson; Thomas L Eggerman
Journal:  J Biol Chem       Date:  2010-01-14       Impact factor: 5.157

Review 7.  Lipoprotein-based drug delivery.

Authors:  Sara Busatto; Sierra A Walker; Whisper Grayson; Anthony Pham; Ming Tian; Nicole Nesto; Jacqueline Barklund; Joy Wolfram
Journal:  Adv Drug Deliv Rev       Date:  2020-08-11       Impact factor: 15.470

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.